Response to “Anticancer Drug Approval in China: From Acceleration of Access to Certainty of Benefits”

Health Data Science · Published 2025-01-01 · DOI 10.34133/hds.0337

Authors being retrieved — see the publisher record. https://doi.org/10.34133/hds.0337

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• An Algorithm for Identifying Microvascular Complications in Type 1 Diabetes in Clinical Setting: Development and External Validation · Health Data Science · 2026 · Same journal
• In-Hospital Mortality Prediction among Intensive Care Unit Patients with Acute Ischemic Stroke: A Machine Learning Approach · Health Data Science · 2025 · Same journal
• Projected Prevalence and Economic Burden of Alzheimer’s Disease and Related Dementias in China: Regional Disparities and Policy Implications · Health Data Science · 2025 · Same journal
• Electronic Health Record-Based Machine Learning Model for Predicting Disease Activity in Patients with Rheumatoid Arthritis · Health Data Science · 2026 · Same journal
• A Scoping Review of Deep Learning Methods for Photoplethysmography Data · Health Data Science · 2026 · Same journal
• Medical AI across data regimes to promote proactive health · Health Data Science · 2026 · Same journal
• Multiscale Contextual Mamba: Advancing Psychiatric Disorder Detection across Multisite Functional Magnetic Resonance Imaging Datasets via State Space Modeling · Health Data Science · 2025 · Same journal
• Aligning Climate Mitigation, Air Pollution Control, and Healthy Aging · Health Data Science · 2026 · Same journal
• Global Inequality and Injustice in Mortality Burden from Floods and Landscape Fire-Sourced Air Pollution · Health Data Science · 2026 · Same journal
• Anticancer Drug Approval in China: From Acceleration of Access to Certainty of Benefits · Health Data Science · 2025 · Same journal